INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTA..

64th Annual ISTH SSC Meeting

 

18-21 July 2018 Dublin
Close
N. Poster
Poster title
Applicant name
Status
  PB-001 Platelet Chemokine Receptor CXCR7 Mediates an Anti-thrombotic and Anti-thromboinflammatory Effect Madhumita Chatterjee Received Received
  PB-002 Ticagrelor Inhibits Platelet-induced Formation of Neutrophil Extracellular Traps Iraklis C. Moschonas Received Received
  PB-007 Beta-1,4-galactosyltransferase 2 c.909C>T Gene Variant Is Predictive of On-clopidogrel Platelet Reactivity Tiphaine Belleville-Rolland Received Received
  PB-008 High On-treatment Platelet Reactivity (HTPR) on Clopidogrel but Not on Novel P2Y12 Antagonists in Patients with ACS Undergoing PCI - Single Centre Study Ján Staško Received Received
  PB-009 Detection of Anthocyanins Effects to Alleviating Thrombotic Risks in Comparison to Aspirin Almottesembellah Gaiz Received Received
  PB-011 Assessment of Clopidogrel Response in Patients with Prior Atherothrombotic Events Zühre Kaya Received Received
  PB-014 Results of Platelet Aggregation Testing by Light Transmission Aggregometry using Drug Specific Agonists in Patients Taking Antiplatelet Therapy Sandra Margetic Received Received
  PB-017 Impact of Time-to-treatment on Freedom-from-relapse for Steroid-Refractory Immune Thrombocytopenia Prakash Vishnu Received Received
  PB-018 Guidance on the Diagnosis and Management of PT-VWD: A Project from the Platelet Physiology Subcommittee of the ISTH Maha Othman Received Received
  PB-019 PK Simulation of Avatrombopag-induced Increases in Platelet Counts with Redosing in Patients with Thrombocytopenia and Chronic Liver Disease Kavita Aggarwal Received Received
  PB-020 Exploratory Analyses of the Efficacy of Avatrombopag versus Placebo from 2 Phase 3 Studies Using Alternate Baseline Platelet Count Cohorts and an Alternate Secondary Efficacy Endpoint Kavita Aggarwal Received Received
  PB-021 Influence of Preoperative Platelet Activity on Coagulation and Blood Loss in Large Orthopedic Surgery Irina Antropova Received Received
  PB-022 Superiority of Avatrombopag to Placebo in Increasing Platelet Counts and Reducing Platelet Transfusions in Patients with Chronic Liver Disease-associated Thrombocytopenia Undergoing Scheduled Procedures - Pooled Analysis of 2 Randomized Phase 3 Studies Kavita Aggarwal Received Received
  PB-023 Atypical Presentations of RUNX1 Associated Familial Platelet Disorder with Predisposition to Myeloid Malignancy (FPDMM) Christopher Ward Received Received
  PB-024 Population PK/PD Modeling of Avatrombopag in Patients with Thrombocytopenia and Chronic Liver Disease - Guided Phase 3 Dose Selection Kavita Aggarwal Received Received
  PB-026 Bloody Diarrhea with Thrombocytopenia in Male Children: Think of Wiskott Aldrich Syndrome Deepti Suri Received Received
  PB-027 Pseudothrombocytopenia: Beyond Platelets Aggregates Anália Carmo Received Received
  PB-028 Coagulation Abnormalities in Dengue and Dengue Hemorrhagic Fever Patients in Pakistan Jawad Hassan Received Received
  PB-030 Acquired Platelet Function Defect and Moderate Cutaneous Bleeding in a Patient on Treatment with a Leukotriene Receptor Antagonist for Asthma Marina Marchetti Received Received
  PB-031 Pelvic Hematoma Secondary to Glanzmann´s Thrombasthenia: A Case Report Siong Leng Hon Received Received
  PB-033 Platelet´s Disorder in a Case of Chronic Lymphocytic Leukemia Corrado Lodigiani Received Received
  PB-035 Dichotomous Cytosolic Mobilization of Calcium, Sodium and Potassium Ions during Procoagulant COAT Platelet Formation Alessandro Aliotta Received Received
  PB-036 Emerging Value of Platelet Function Testing at Predicting the Risk of Recurrent Vascular Events and Outcomes after TIA/Ischemic Stroke: A Systematic Review of the Literature Soon Tjin Lim Received Received
  PB-037 Lysis of Blood Cells by Arachidonic Acid Cause ADP-dependent Platelet Activation Responses in Platelet Function Tests using Whole Blood Sofia Ramstrom Received Received
  PB-038 Assessment of Platelet Count Standardization in Platelet-rich Plasma for Platelet Function Testing by Light Transmission Aggregometry Mason Dixon Received Received
  PB-039 Kinetic Application of Flow Cytometry for Patients with Unknown Bleeding Disorders: The Underestimated Value of Mepacrine Georgi Manukjan Received Received
  PB-040 The Gp1ba-Cre Transgenic Mouse: A New Model to Delineate Platelet and Leukocyte Functions Zoltan Nagy Received Received
  PB-041 The Fluidity of Platelet Membrane an Important Parameter for Platelet Function in Chronic Myeloproliferative Neoplasms Patients Viola Maria Popov Received Received
  PB-042 The Effect of FXa on Platelet Activation, in vitro Styliani Papadaki Received Received
  PB-043 Functional Validation of microRNA-126-3p as a Platelet Reactivity Regulator using Human Progenitor Cells Alix Garcia Received Received
  PB-044 Assessment of Light Transmission Aggregometry on the Routine Coagulation Analyzer Siemens CS-2500 using CE-marked Agonists from Hyphen Biomed Mathieu Fiore Received Received
  PB-047 Influence of Sample Platelet Count on Three Common Platelet Function Tests: A Comparative Study Anna L. Södergren Received Received
  PB-048 Comparison of PAC-1 and a-fibrinogen Antibody Binding to Platelet Subpopulations Anna L. Södergren Received Received
  PB-049 Assessment of Neonatal Platelet Granule Trafficking and Shear-induced Platelet Activation in Neonatal Peripheral and Cord Blood Anh Ngo Received Received
  PB-053 Platelets Role in the Plasma Clotting is Not Limited to Providing a Lipid Surface Anna Balandina Received Received
  PB-054 Stability of Platelet Function in Healthy Individuals over a One-year Period Mark Roest Received Received
  PB-055 The Canine Platelet Secretome (CAPS): Proteomic Analysis of Thrombin-stimulated Release Signe Emilie Cremer Received Received
  PB-057 Mean Platelet Volume Positively Correlates with Uterine Volume after Menopause, Except Myomas Presence Bibiána Bajteková Received Received
  PB-061 Flow Cytometric Analysis of Platelet Function in Patients on Antiplatelet Therapy and Suspected Thrombocytopathy Dana Huskens Received Received
  PB-062 Characterization of Platelet Function with Flow Cytometry for Bleeding Risk Evaluation in Hematological Disorders Anastasia Ignatova Received Received
  PB-065 Usefulness of Optical Aggregometry and Flow Cytometric Studies as a Complementary Tools in Patients with Acquired Platelet Defects (APD) Analia Sanchez-Luceros Received Received
  PB-066 Platelet Function in Polycythemia Vera and Primary Myelofibrosis Using Multiple Electrode Aggregometry Nikolaj Skrøder Nytofte Received Received
  PB-067 Platelet to Lymphocyte Ratio was Significantly Lower for Slovak Postmenopausal Women Born from November to April, Except those with Leiomyoma Bibiána Bajteková Received Received
  PB-069 A Novel Role of LASSBio-788 in Inhibiting NF-?B Mediated Signaling in Platelet of Hypercholesterolemic Rats: Would Be New Antiplatelet Agent? Nadia Alice Vieira Motta Received Received
  PB-070 New Clinicopathologic Finding in a Patient with Acquired Amegakaryocytic Thrombocytopenia Treated with Thrombopoietin Receptor Agonist Therapy eva hortas Received Received
  PB-075 Evidence of a Dominant Negative Effect of Gain-of-Function ITGB3 Mutations over Loss-of Function Mutations in Variant Glanzmann Thrombasthenia Loredana Bury Received Received
  PB-076 Bleeding Diathesis Associated with Severe Acquired Platelet Dysfunction and Overproduction of Cyclic AMP in Two Patients with Hematologic Malignancies Andrea Artoni Received Received
  PB-077 In-silico Prediction of Molecular Mass Distance Dependent Changes in Binding Energies between von Willebrand Factor and Platelet Membrane Glycoprotein (GP) Iba in Wild Type and G233V Mutant Shinichi Goto Received Received
  PB-079 Investigation of Polymorphic Variations in Glutathione S Transferase Genes among Immune Thrombocytopenia Patients in Pakistan Samina Naz Mukry Received Received
  PB-081 CD8 T Cell-mediated Platelet Clearance Does Not Occur via Traditional Cytotoxic Protein Killing Cheryl Maier Received Received
  PB-082 Human Platelets Labeled at Multiple Biotin Densities: A Promising Approach for Monitoring in vivo Platelet Survival in Clinical Trials Catherine Ravanat Received Received
  PB-083 Quantitative Alteration of Vesicle Associated miRs and RISC Complex Reflect Platelet Concentrate Molecular Pattern during Storage as Platelets Activity Model Vasilii Kishenko Received Received
  PB-084 Improving Transfusion Safety by Implementing Platelet Bacterial Screening in a Resource-limited Country Farheen Karim Received Received
  PB-089 Compensatory Effect of Fibrinogen in Patient with Bone Marrow Aplasia, Septic Shock and Severe Thrombocytopenia Guided by Thromboelastometry: A Case Report Tomaz Crochemore Received Received
  PB-090 A Novel Murine Model of Immune Thrombocytopenia Induced by Immunized CD41 Knockout Mice Xin Li Received Received
  PB-092 Effects of Bothrops jararaca Venom on Platelet Aggregation, Secretion and Protein synthesis Marcelo L. Santoro Received Received
  PB-095 Janus Kinase 3 (JAK3)-dependent Signaling Is Critical to Ca2+-dependent Platelet Activation and Thrombus Formation Mailin Manke Received Received
  PB-098 Role of Protease-activated Receptor 4 in Regulating Platelet Dense Granule Release Tiffany Chu Received Received
  PB-103 S100A9 Activates Platelets via RAGE Saskia von Ungern-Sternberg Received Received
  PB-105 Induced Apoptosis-like Changes Caused by Sirtinol, a Pharmalogic Inhibitor of Sirt1/2, in Human Platelets Ram L. Mallick Received Received
  PB-106 Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) in the Pathogenesis of Immune Thrombocytopenia Elif Umit Received Received
  PB-107 Patients with Aortic Stenosis Have von Willebrand Factor Abnormalities and Aberrant Angiogenesis in BOEC Soundarya Nivedita Selvam Received Received
  PB-108 High-dose Dexamethasone Alters the Increase in IL-16 Level in Adult Immune Thrombocytopenia Xinyi Zuo Received Received
  PB-109 Progranulin Facilitates the Increase of Platelet Count in Immune Thrombocytopenia Xinyi Zuo Received Received
  PB-110 The Aberrant Expression of microRNAs in B Lymphocytes of Patients with Immune Thrombocytopenia Xi Jia Received Received
  PB-111 A Novel Model using Protein C-to-INR Ratio to Predict Short-term Mortality in Cirrhosis Anupama Patil Received Received
  PB-112 Increased Cytotoxic Potential of CD8 T Cells in Patients with Immune Thrombocytopenia John R Vrbensky Received Received
  PB-113 Gene Expression of Vanin-1 (VNN-1) in Egyptian Adults with Immune Thrombocytopenia (ITP): A Single Center Experience Doaa El Demerdash Received Received
  PB-115 Real-life Bleeding Risk of Anti-factor Xa Direct Oral Inhibitors; Does Prothrombin Complex Concentrate Work? Buddhika Badugama Received Received
  PB-117 Is the Profile of Patients with Intracranial Hemorrhage Changing? Sarah Reeves Received Received
  PB-120 Noonan Syndrome and Bleeding Disorders: An Overview of Current Diagnostic Management C.H. van Ommen Received Received
  PB-121 Long-Term Follow-up of Children on Prophylaxis for Severe Factor VII Deficiency in Lebanon Roula A. Farah Received Received
  PB-122 Clinical Presentations and Diagnostic Algorithm of Neonatal FXIII-deficiency Mehran Karimi Received Received
  PB-123 Effectiveness of Pediatric Bleeding Questionnaire in Hemorrhagic Disorders Laura Villarreal Martinez Received Received
  PB-124 Surgical Management of Rare Factor Deficiencies Erol Erduran Received Received
  PB-127 Plasma Profile of Platelet Auto-antibodies in Patients with Thrombocytopenia in Pregnancy Wenhong Shen Received Received
  PB-131 Translation and Validation of the Pictorial Blood Loss Assessment Chart (PBAC) in Arabic Ons Kaabia Received Received
  PB-132 Diagnosis Value of Screening Tools for Hemostasis Disorders in Women Consulting for Prolonged Menstruation with Normal Pelvic Exam Ons Kaabia Received Received
  PB-133 Clinical Screening for Underlying Bleeding Disorder in Nigerian Women Theresa Nwagha Received Received
  PB-134 Hemostasis Disorders in Tunisian Women with Non Organic Menorrhagia: A Case Control Pilot Study Ons Kaabia Received Received
  PB-135 Improving the Gynaecological Management of Women with Bleeding or Thrombotic Disorders by Multi-professional Out-patient Care Kathryn Mary Musgrave Received Received
  PB-136 A Woman´s Life-long Bleeding Condition: Diagnostic Dilemma and Expert Opinion Rochelle Winikoff Received Received
  PB-137 Thrombocytopenia in Pregnancy: The Role of Hemostasis Laboratory for Diagnosis and Management of Acute Fatty Liver of Pregnancy Giuseppe Rescigno Received Received
  PB-139 Does Hemophilia Slow Down the Development of Liver Fibrosis? Marie-Astrid van Dievoet Received Received
  PB-140 Geno- and Phenotype Correlate in Porcine Model of von Willebrand Disease Type 1 and Type 3 Hanna Allerkamp Received Received
  PB-142 Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B Massimo Morfini Received Received
  PB-148 Circulating Biochemical Markers of Early Joint Bleeding: Validation Study in Humans Narine Hakobyan Received Received
  PB-152 Whole F8 and VWF Gene Sequencing using Next-generation Sequencing for Mutation-negative French and Canadian Hemophilia A Patients Fanny Lassalle Received Received
  PB-153 Within-patient Comparison of Treatment Patterns before and after Switching to rFIXFc: A Report from the UK National Haemophilia Database Martin Scott Received Received
  PB-154 Arthropathy and Joint Replacement Surgery in Patients with Hemophilia A (PwHA) in the US Anisha Patel Received Received
  PB-155 Extended Half-life Factor Concentrate Use for Patients with Moderate and Severe Hemophilia among ATHN-affiliated U.S. Hemophilia Treatment Centers Stacy E. Croteau Received Received
  PB-156 Genetic Polymorphisms Contributing to the Pharmacokinetics of Factor VIII Concentrates Massimo Morfini Received Received
  PB-157 Real World Data Analysis of US Claims Database on Coagulation Factor VIII Expenditures in Patients with Hemophilia A: Standard Half-life vs. Extended Half-life Products Bartholomew Tortella Received Received
  PB-158 Measuring FIX-Activity of Nonacog Beta Pegol (N9-GP) in a One-stage Ellagic Acid Based Clot Assay on the ACL TOP 50 Series Instrument: A Two-site Study Mary Doyle Received Received
  PB-161 Correlation of Factor Levels with Bleeding Phenotype in Non-severe Hemophilia Ingrid Pabinger Received Received
  PB-164 Burden of Mild Hemophilia A: Systematic Literature Review Eva Hortas Received Received
  PB-165 Realworld Health Care Expenditure and Dispensation of Extended and Standard Half-life Recombinant Factor IX Products in Hemophilia B Patients Bartholomew Tortella Received Received
  PB-168 The Effect of Unmeasurable Endogenous Plasma Factor Activity Levels on Factor VIII Dosing in Patients with Severe Hemophilia A Pierre Chelle Received Received
  PB-171 Are Current Therapeutic Strategies with Conventional Products Sufficient to Manage the Burden of Haemophilia in Italy? eva hortas Received Received
  PB-172 Practical Considerations in Choosing a Cost-effective and-Efficient Solution for Prophylaxis in Haemophilia Margit Serban Received Received
  PB-179 The Bone Disease in Haemophilia: The Role of von Willebrand Factor, Factor VIII and Thrombin Stefano Lancellotti Received Received
  PB-181 Standardized Determination of FVIII Inhibitors with the Improved FVIII INH Kit Lieselotte Wagner Received Received
  PB-185 Joint and Functional Assessment Following Secondary and Tertiary Prophylaxis in PWH who were Previously Receiving Episodic on Demand Factor Replacement Infrequently Anupam Dutta Received Received
  PB-187 Epidemiological Survey and Audit of Socio-demographic Characteristics of Patients with Haemophilia and other Congenital Bleeding Disorders Helen Okoye Received Received
  PB-188 Development of a FVIII Antigen Assay to Quantify B-domain Deleted FVIII Antigen in Human Plasma eva hortas Received Received
  PB-192 Hemophilia A Subjects with an Intron-22 Inversion Mutation Show Robust T-cell Responses to Epitopes in Both the FVIII Heavy and Light Chain Kathleen P. Pratt Received Received
  PB-197 Potential Clinical Trial Validation of Differential EPCR-dependent Activity by Eptacog Beta, a rhFVIIa Variant, in the Treatment of Bleeding in Hemophilia Patients with Inhibitors Jonathan Ducore Received Received
  PB-200 Risk Modeling Inhibitor Development of Haemophilia A Patients in Australia Sumit Parikh Received Received
  PB-203 Successful Eradication of Factor FVIII Inhibitor by Cyclophosphamide Treatment in a Patient with Acquired Haemophilia A - A Case Report Sandra Margetic Received Received
  PB-204 Clinical Description and Laboratory Characterization of Heparin-like Substance Causing Bleeding Jun Teruya Received Received
  PB-206 Skeletal and Cardiac Muscle Myosin Exert Procoagulant and Antifibrinolytic Effects Julia Coleman Received Received
  PB-210 Platelet-nanocapsule Hybrids for On-demand, Targeted Delivery of Factor VIII in Hemophilia A Mice Caroline E. Hansen Received Received
  PB-211 Annualized Bleeding Rates, the Current Favorite Clinical Endpoint in Hemophilia Trials: Pitfalls and Caveats Christine Keipert Received Received
  PB-214 Tranexamic Acid Reduces Post-surgical Infection Rates via Direct Immune Cell Modulation Dominik F. Draxler Received Received
  PB-215 ROTEM® or Conventional Hemostasis Test: Experience in Cardiac Surgery Setting Isabelle Gouin-Thibault Received Received
  PB-216 A New, Hand-held, Multifunctional Coagulation Laboratory for Perioperative Monitoring Seemantini Nadkarni Received Received
  PB-218 Monitoring Anticoagulation and Hemostasis in Cardiac Surgical Patients with a Drop of Whole Blood Diane Malu Tshikudi Received Received
  PB-219 Short-term Recovery Pattern of Plasma Fibrinogen after Cardiac Surgery: A Prospective Observational Study Gabor Erdoes Received Received
  PB-221 Classification of Surgical Bleeding Situations Richard Kocharian Received Received
  PB-222 Recombinant Factor VIIa (Novoseven®) Utilization and Safety for Refractory Bleeding After Cardiac Surgery at a Large Academic Medical Center Tania Ahuja Received Received
  PB-224 Thromboelastometry-guided Therapy for the Treatment of Hemorrhagic Shock in Postoperative of Vascular Surgery: A Case Report Tomaz Crochemore Received Received
  PB-225 Analysis of Fresh Frozen Plasma Requirement in Post Cardiopulmonary Bypass Cardiac Surgery Patient Based on Standard Coagulation and Thrombelastography Tests in Hasan Sadikin Hospital, Bandung Leni Lismayanti Received Received
  PB-226 Quality and Accuracy of Testing for von Willebrand Disease by North American Special Coagulation Laboratories from 2010 to 2017 Jameel Abdulrehman Received Received
  PB-227 FXI-deficient Patients with Bleeding Phenotype Show a Spatio-temporal Propagation of Blood Coagulation Shorter and Slower than Normal Debora Bertaggia Calderara Received Received
  PB-228 The FVIII: C Measurement of Extended Half-life Recombinant Factor VIII FC Fusion in Haemophilia A Patients Annette Bowyer Received Received
  PB-229 Overassignment of Recombinant Wild Type (rwt) FIX Potency by a One-stage Method Indicated from Comparison with Chromogenic FXIa and TF/FVIIa Based Methods and through Discrepant Activation of rwt FIX and Plasma Derived (pd) FIX by Plasma Kallikrein (PK) Steffen Rosén Received Received
  PB-230 Sensitive and Standardized TGA Measurement in Haemophilia Patients Using Ceveron® Alpha TGA Nikolaus B. Binder Received Received
  PB-231 Differences in FVIII Measurements of Plasma Spiked with AFSTYLA® Generated with One-stage Clotting Assay using Different Commercial APTT Reagents Compared with Chromogenic Method Inge Vangenechten Received Received
  PB-233 Pre - analytical Variables - Sample Rejection in Hemostasis Laboratories Lilia Brown Received Received
  PB-234 Thromboelastometry Profile in Critically Ill Patients: A Single-center, Retrospective, Observational Study Tomaz Crochemore Received Received
  PB-235 Differences in Activity of Plasma Spiked with IDELVION® Generated with One-stage Clotting Assay using Different Commercial APTT Reagents Compared with Chromogenic Method Inge Vangenechten Received Received
  PB-236 Extended Half-life Factor VIII: From Biology to Patients´ Management Optimization Andreas Perrier-Cornet Received Received
  PB-237 Evaluation of an Automated Chromogenic Assay for Measuring FVIII:C Levels in the Patients Affected by Hemophilia A Cristina Novembrino Received Received
  PB-238 Underassignment of FIX Potency of rFIX-Albumin Fusion Protein (rFIX-HSA) by One Stage Methods Demonstrated in Studies on FXIa and FIXa Generation Steffen Rosén Received Received
  PB-239 Correlation of FIX Activity Assays with Thrombin Generation Lisa Florin Received Received
  PB-243 One Stage and Chromogenic Assays Discrepancy in the Estimation of Factor IX (FIX) Recovery. What is it that a Single Hemophilia Center Can and Cannot Do? Jovan P Antovic Received Received
  PB-244 Comparison of Two One-stage Clotting Assays and One Chromogenic FIX Assay for Monitoring of Idelvion® Replacement Therapy Lisa Florin Received Received
  PB-245 Levels of Coagulation Factors, Coagulation Inhibitors and TAFI Do Not Affect Global Hemostasis and Bleeding Phenotype in Patients with Hemophilia A Jovan Antovic Received Received
  PB-247 The Effect of DDAVP on Thrombin Generation in Patients with Bleeding Disorders Alexandra Agapidou Received Received
  PB-249 Comparison of Three Thromboplastin Reagents for International Normalized Ratio (INR) Measurement in Patients on Vitamin K Antagonist Therapy Francois Depasse Received Received
  PB-251 External Quality Assurance (EQA) for the Rotem Sigma Thromboelastometry Device Dianne Kitchen Received Received
  PB-252 Stored Calibration Curves Can Deliver Acceptable Accuracy and Precison on CS5100 Analysers Anne Sermon-Cadd Received Received
  PB-253 Measurement of Immunoglobulins Anti VWF in Patients with Probable AVWS with an Enzyme-linked Immunosorbent Assay (ELISA) Using Platelet VWF as an Antigen Analia Sanchez-Luceros Received Received
  PB-254 Performance Evaluation of Automated Thrombin Generation Measurement on Ceveron®alpha TGA Lieselotte Wagner Received Received
  PB-255 Calibrations Performed in the Lab Fail to Correct Fibrinogen Quality Control Variability Generated by Different Reactant Batches Felipe Guerrero Received Received
  PB-257 Variations in Automated Platelet Counts Occur Depending on the Principle Used for Cell Counting and on the Non-platelet Blood Cell Parameters Ganesh Kumar Viswanathan Received Received
  PB-258 Accuracy and Precision of Point-of-Care International Normalized Ratio (INR) in Pediatric and Adult Patients with Liver Disease Pilot Study Patricia Sachi Kawada Received Received
  PB-259 Clearance of Mouse VWF Propeptide Is Mediated by Stabilin-2 and Is Regulated by N-linked Glycan Expression Orla Rawley Received Received
  PB-261 Expression of the SCARA5 Scavenger Receptor in the Human Kidney and Spleen May Regulate Clearance of VWF Laura L Swystun Received Received
  PB-262 Diverse Inheritance of VWD Found in Type 3 U.S. Families in the Zimmerman Program Pamela Christopherson Received Received
  PB-264 High Molecular Weight von Willebrand Factor Multimers in Cryoprecipitate Exceed that Found in a Commercial Concentrate Meaghan Elizabeth Colling Received Received
  PB-270 Molecular Analysis and Bleeding Phenotype of Seven Severe FV-deficient Patients from Pakistan Munira Borhany Received Received
  PB-271 Rare Bleeding Disorders in Pakistan: An Update Munira Borhany Received Received
  PB-272 Functional Polymorphisms of the von Willebrand Factor Gene in Patients with Mild to Moderate Bleeding Tendency and Low or Normal von Willebrand Factor Antigen or von Willebrand Factor Ristocetin Cofactor Stefanie Hofer Received Received
  PB-273 Comparison of a von Willebrand Factor Fully-automated Chemiluminescent Assay Panel for von Willebrand Disease Diagnosis to and Historical Classification Luciano Baronciani Received Received
  PB-275 Correction of Factor XI Deficiency by Liver Transplantation for Secondary Sclerosing Cholangitis Corinne Frere Received Received
  PB-276 Intense Exercise Increases von Willebrand Factor and Factor VIII Levels in Well-trained Athletes Paraskevi Spatharaki Received Received
  PB-277 Prevalence of von Willebrand Disease among Nigerian Youths in Ibadan South-Western Nigeria Wuraola Shokunbi Received Received
  PB-278 Impact of Mitral Valve Clip Procedure on Indices of Acquired von Willebrand Syndrome Joseph Blackshear Received Received
  PB-279 Comparative Study of Single Nucleotide Polymorphisms (SNPs) in the Exon 28 of the VWF between Healthy Donors, VWD2M (with p.E1549K and p.R1374C) and VWD2B Patients (with p.R1308C and p.V1316M) in a Single Center in Argentina. Preliminary Report Analia Sanchez-Luceros Received Received
  PB-280 Genotyping of Five Patients with Severe Inherited Factor X (FX) Deficiency from Pakistan: Identification of Two Novel Mutations Munira Borhany Received Received
  PB-282 Discrepant von Willebrand Factor (VWF) Activity Levels in Two Unrelated von Willebrand Disease (VWD) Patients Mackenzie Bowman Received Received
  PB-284 Are Iranian Patients with von Willebrand Disease Type 2N Properly Differentiated from the Ones with Mild/Moderate Hemophilia A and Do They Receive Appropriate Treatment? Asghar Seidi Zadeh Received Received
  PB-285 Polyphoshate Nanoparticles Slow Down the Clotting of Fibrinogen and Increase the Lytic Stability of Fibrin Miklós Lovas Received Received
  PB-286 Alternative Complement Pathway Inhibits Fibrinolysis in an in-vitro Whole Blood Model Jason Samuels Received Received
  PB-290 Novel Fibrinogen Missense Mutations in Patients with Fibrinogen Defects Elvira Grandone Received Received
  PB-293 Increased Fibrinolysis as a Specific Marker of Poor Outcome after Cardiac Arrest Michael Schwameis Received Received
  PB-295 Euglobulin Lysis Time (ELT) Behaviour in Patients Wwith Abnormal Clot Solubility Test (CST) Lucia Remotti Received Received
  PB-296 Association between Use of Recombinant Tissue Plasminogen Activator and In-hospital Mortality and 30-day Readmission among Ischemic Stroke Patients Undergoing Mechanical Thrombectomy: A Retrospective Cohort Study Joshua Brown Received Received
  PB-297 Staphylokinase Potentiates Thrombolytic Effect of Single Chain Pro-urokinase in Plasma Milleu in vitro Roza Aisina Received Received
  PB-298 Local Ultrasound-facilitated Thrombolysis in Pulmonary Embolism: First Dutch Experience and Retrospective Comparison with Systemic Thrombolysis Maria Adriana de Winter Received Received
  PB-302 Clot Formation Assessment in Septic Patients with Cancer using a Time-based Parameter from the ROTEM Velocity Curves. A Prospective Observational Pilot Study Ecaterina Scarlatescu Received Received
  PB-303 Increase in Plasma Stability and Thrombolytic Efficacy of pro-UK by Chemical Modification of its Arginine Residues Liliya Mukhametova Received Received
  PB-307 Gender Differences in TAFI Regulation in Some Disorders Eugene Roitman Received Received
  PB-309 The Role of Plasminogen Activator Inhibitor-1 (PAI-1) Levels and PAI-1 4G/5G Polymorphism in the Outcome of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients Zsuzsa Bagoly Received Received
  PB-314 Different Pattern of Platelet Binding to Monocytes in Healthy Volunteers and in Patients with Coronary Artery Disease Marina Loguinova Received Received
  PB-315 Pharmacological Actions of Inosine in a Hypercholesterolemic Model: Is It a New Antiatherosclerotic Drug? Gabriel Ferreira Lima Received Received
  PB-316 Cement Dust Exposure Associated with Anaemia, Increased Platelets, Cardiac Markers and Dyslipidamia among Male Cement Workers in Calabar, Nigeria Ifeyinwa Maryann Okafor Received Received
  PB-317 Hyperhomocysteinemia and endothelial Dysfunction of the Athletes in the Arctic Region Nadezda Vorobyeva Received Received
  PB-318 Folate Deficiency of the Nenets of the Arctic Regions of the Russia Nadezda Vorobyeva Received Received
  PB-322 Recombinant Human Soluble Thrombomodulin Protects Vascular Endothelial Cells from Radiation-induced DNA Damage Takayuki Ikezoe Received Received
  PB-324 Ubiquitin-driven p38 Inflammatory Signaling Induced by Protease-activated Receptors Joann Trejo Received Received
  PB-326 The Anti-coagulant Vitamin K-dependent Factor, Protein S, Alters Endothelium Functions by Regulating Multiple Vascular Permeability Related Signaling Pathways Omar Benzakour Received Received
  PB-327 Simultaneous Assessment of sE-Selectin, Platelet Count and Mean Platelet Volume as Biomarkers for Pre-eclampsia Maha Othman Received Received
  PB-330 Comparison of Syndecan-1 Levels as a Marker of Endotheliopathy in Thermal Injury and Blunt Trauma Robert Ball Received Received
  PB-332 Ceramide 1 Phosphate Protects Human Endothelial Colony Forming Cells from Apoptosis and Increase Their Angiogenic Responses Hebe Agustina Mena Received Received
  PB-333 Ticagrelor Induces the Expression of the Endothelial Phenotype CD34+ Progenitor Cells in the Presence of ADP via an Adenosine-mediated Mechanism Alexandros D. Tselepis Received Received
  PB-334 Coxsackievirus B3 Replicates in Endothelial Colony Forming Cells and Inhibits Angiogenesis Paula Romina Zubiry Received Received
  PB-335 Circulating Progenitor and Mature Endothelial Cells in Patients with Venous Thromboembolic Disease Sofia Grille Received Received
  PB-337 PAR-1 Inhibition Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Endotoxemia Christian Schoergenhofer Received Received
  PB-340 Type I Interferons Upregulate IFITM3 in Human Platelets and Megakaryocytes to Control Viral Infectivity Robert Campbell Received Received
  PB-341 Sphingosine 1-phosphate Induces COX-2/PGE2 Expression via PKCalpha-mediated MAPKs and NF-kappaB Cascades in Human Cardiac Fibroblasts Chuen-Mao Yang Received Received
  PB-342 Utility of New Red Cell Parameters for Identifying Functional Iron Deficiency and Anemia in Patients with Familial Mediterranean Fever Zühre Kaya Received Received
  PB-343 The Role of Cytokines in the Development of Acquired Aplastic Anemia Inna Berger Received Received
  PB-346 Hemoglobin-activated Platelet Regulates Macrophage Polarization under Hemolytic Conditions Rashi Singhal Received Received
  PB-350 Circulating Cholesterol Containing, Platelet-derived Microparticles Contribute to the Procoagulant State Observed in Systemic Lupus Erythematosus Shuaishuai Hu Received Received
  PB-352 Circulating Microparticles Improve Thrombin Generation and Fibrin Formation in Factor VIII Deficiency Plasma Jovan Antovic Received Received
  PB-356 Delayed Initiation and Inadequate Anticoagulation as Independent Risk Factors for Development of Post Thrombotic Syndrome (PTS) - An Observational Study from a Tertiary Care Hospital in North India Vikas Suri Received Received
  PB-357 Mitofusin 2 Regulates Mitochondria in Megakaryocytes, and Hemostasis and Thrombosis in Mice Jesse W. Rowley Received Received
  PB-358 PDK1 Is Crucial to Pro-platelet Formation and Thrombopoiesis by Regulating MK Actin Polymerization Sascha Geue Received Received
  PB-359 Unique Megakaryocytes from Human Adipose-derived Mesenchymal Stromal/stem Cell Line: Comparison with Hematopoietic Stem Cell-derived Megakaryocytes Yukako Ono-Uruga Received Received
  PB-360 Nucleic Acid-based Therapeutic Targets for Protein S Deficient Patients Ross Baker Received Received
  PB-361 Structural Insights during the Recognition of Endothelial Cell Protein C Receptor to the Protein C/activated Protein C in Presence of Phospholipid within EPCR Groove Ramesh Prasad Received Received
  PB-362 Retrospective Study about using Bridging Therapy with Sodium Bemiparin in our Center Pablo Romero Garcia Received Received
  PB-364 Betrixaban: Impact on Routine and Specific Coagulation Assays - A Practical Laboratory Guide Romain Siriez Received Received
  PB-366 Inhibition of Factor XII is Antithrombotic in a Primate Model of Extracorporeal Membrane Oxygenation Michael Wallisch Received Received
  PB-367 Effects of SERPINC1, PROC, PROS1 and EPCR Polymorphisms on the Risk of Venous Thromboembolism and Myocardial Infarction in Young Individuals Zsuzsanna Bereczky Received Received
  PB-368 Structural and Functional Study of Naringin Octasulfate (NOS) on Human Antithrombin and Probing its Role in Thrombus Reduction using Rat Model Irshad Ahmad Received Received
  PB-372 Emicizumab Impact on Factor VIII Inhibitor Determination in Plasma Samples from Persons with Hemophilia A (PwHA) using a New Kit for Modified Nijmegen-Bethesda Assay (MNBA) Ali Sadeghi-Khomami Received Received
  PB-375 Data of Real-life Anticoagulant Treatment with Edoxaban In Patients with Atrial Fibrillation and Patients with Secondary Prevention of Deep Vein Thrombosis. Experience of Thirteen Months in our Center Almudena Garcia Ruiz Received Received
  PB-376 Cross-sectional Survey of Minor Bleeding Rates in Children Prescribed Warfarin Nadia Poci Received Received
  PB-377 Antithrombin Levels in Nigerians with Type2 Diabetes Omolade Augustina Awodu Received Received
  PB-378 Laboratory Algorithm of Diagnostic of Hemorrhagic Diseases in Patients with Isolated Prolonged Activated Partial Thromboplastin Time (APTT) Valeriia Krasivska Received Received
  PB-379 From Tissue Factor to Thrombin to Fibrin under Whole Blood Flow: Thrombin Makes Fibrin but Fibrin Quenches Thrombin Scott Diamond Received Received
  PB-380 Effect of Andexanet-tissue Factor Pathway Inhibitor (TFPI) Interaction on in vitro Clot Formation and Lysis via Different Coagulation Pathways Genmin Lu Received Received
  PB-382 Molecular Sequencing of Factor VII Variants through Collaborative Advocacy for Families in the United States: 154 Individuals Using Multi-gene Next Generation Panel Diane Nugent Received Received
  PB-383 Inappropriate Use of Fresh Frozen Plasma in a Tertiary Care Hospital Sidra Asad Ali Received Received
  PB-385 Clot Waveform Analysis: Determination of Optimal Wavelength to Assess the Fibrin Coagulation Process Jonathan Evrard Received Received
  PB-387 Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia - An Experience fom Resource Constraint Country Nida Anwar Received Received
  PB-389 eNOS, ACE AND PAI-1 Gene Polymorphisms in a Sample of General Population of Northern Greece Androniki Papoutsi Received Received
  PB-391 Association between Factor V Leiden and APCR Values: Data from a Portuguese University Hospital Analia Carmo Received Received
  PB-393 Prevalence of Common Genetic Variants Associated with Thrombophilia in Asymptomatic young Individuals with a Family History of Thrombosis Androniki Papoutsi Received Received
  PB-394 Identification and Differentiation of Coagulation Factors in Prothrombin Complex Concentrates (PCC´s) Maurice Mandago Received Received
  PB-398 FXIa Binds and Forms a Complex with Plasminogen Activator Inhibitor-1 that Inhibits Its Activity and Induces Internalization and Degradation by Endothelial Cells Anh Ngo Received Received
  PB-402 Saliva-derived Tissue Factor Induces Thrombin Generation in a Diurnal Rhythm Lisa N. van der Vorm Received Received
  PB-403 Activated Factor VII Fused with Transferrin Showed Prolonged Half-life with Safe Toxicity Profile in Animal Models InYoung Song Received Received
  PB-404 "Real World" Usage of Prothrombin Complex Concentrates (PCCs) to Correct Coagulopathy. A 3 Year Retrospective Review in an Academic Hospital System Ismini Kourouni Received Received
  PB-405 Gene Expression of Coagulation Factors after Experimental Snake Envenomation in Mice Marcelo Larami Santoro Received Received
  PB-406 Enhanced FIX Collagen IV Binding Shows Improved Hemostatic Effects in a Hemophilia B Mouse Model Davide Matino Received Received
  PB-408 Factor XI Level Is a Determinant of Plasma Clot Growth Cornelis Kluft Received Received
  PB-409 Robustness of Spatial Thrombin Generation and Fibrin Clot Propagation Anna Kuprash Received Received
  PB-410 The Blood Clot is Covered by a Fibrin Film that Protects against Microbes Fraser Macrae Received Received
  PB-411 Binding of Coagulation Factor XIII Zymogen to Activated Platelet Subpopulations: Roles of Integrin aIIbß3 and Fibrinogen Nadezhda Podoplelova Received Received
  PB-412 Presence and Function of Cellular Factor XIII in Human Cornea Zsuzsanna Z. Orosz Received Received
  PB-413 The Effect of Factor XIII Levels on the Incorporation of a2-plasmin Inhibitor into Fibrin Clots: Association with the Therapeutic Outcome of Acute Ischemic Stroke Patients Zsuzsa Bagoly Received Received
  PB-415 Fibrin Fiber Mechanical and Structural Properties Are Altered in Individuals with Cardiovascular Disease on Low/Medium Dose Aspirin Martin Guthold Received Received
  PB-416 Factor XIII Concentrate Can Improve Clot Stabilization Guided by Thromboelastometry in Patient with Liver Disease: A Case Report Tomaz Crochemore Received Received
  PB-418 Plasma Fibrinogen Concentration As an Acute Marker of Myocardial Infarction Chinedu Kingsley Dike Received Received
  PB-419 Apixaban Does Not Generate False-positive dRVVT Interpretations for Lupus Anticoagulants, Even at Peak Levels Osamu Kumano Received Received
  PB-422 Antiphospholipid Syndrome: Maternal and Perinatal Outcome after Treatment in Next Pregnancy. Retrospective Analysis Beatriz Grand Received Received
  PB-423 Are IgM Antiphospholipid Antibodies Redundant in the Classification Criteria for the Antiphospholipid Syndrome? Walid Chayoua Received Received
  PB-424 A Single-arm Pilot Feasibility Cohort Study of Rivaroxaban in Antiphospholipid Syndrome Mark Crowther Received Received
  PB-426 Use of Direct Oral Anticoagulant in Antiphospholipid Syndrome: Systematic Review of Literature Denis Wahl Received Received
  PB-431 Evaluation of Lupus Anticoagulant Testing: A Descriptive Single Centre Experience Sergio Felipe Pinzon Mariño Received Received
  PB-433 A Comparison between Mixing Test Specific Cut-off and the Index of Circulating Anticoagulant with Multiple APTT and dRVVT in Specificity for Lupus Anticoagulant Osamu Kumano Received Received
  PB-434 Thrombotic Risk Assessment in Antiphospholipid Syndrome Analia Carmo Received Received
  PB-436 Recent Metods for Laboratory Detection of Lupus Anticoagulant in Patients with Antiphospholipid Syndrome Valeriia Krasivska Received Received
  PB-439 Direct Oral Anticoagulants in Venous Thromboembolic Disease; Boon or Bane? Andrea Ang Received Received
  PB-440 Outcomes in Non-valvular Atrial Fibrillation Patients with Good and Poor INR Control after Switching to Direct Oral Anticoagulants Scott Kaatz Received Received
  PB-441 PK/PD (Thrombinography and Fibrinography) Response Variability to Rivaroxaban in Patients Aged 80 Years and Older with Atrial Fibrillation: Results of the ADAGE Study Geoffrey Foulon Received Received
  PB-442 Health-related Quality of Life after Pharmacomechanical Catheter-directed Thrombolysis for Proximal Deep Vein Thrombosis Susan R. Kahn Received Received
  PB-443 DTI/DXI Interferences with Global Coagulation Tests in Daily Care Emergency Admissions - Results of the Prospective DRESDEN NOAC REGISTRY (NCT01588119) Jan Beyer-Westendorf Received Received
  PB-444 Evaluation of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of the Anti-factor XI Antibody, AB023, in Healthy Adult Volunteers Christina U. Lorentz Received Received
  PB-445 The Indirect Effects of Dabigatran En Rivaroxaban on Fibrinolysis Suzanne Zwaveling Received Received
  PB-446 Risk of Thrombosis and Bleeding in Patients Treated with Warfarin or Apixaban for Non-valvular Atrial Fibrillation: A Large, National, Retrospective Study Matthew Wanat Received Received
  PB-447 Novel Universal Antidote to Non-Vitamin K Antagonist Anticoagulants Georges Jourdi Received Received
  PB-448 Comparing the Proportions of Patients that Meet Criteria for Extended Prophylaxis with Betrixaban Based on APEX Trial and FDA Indication Scott Kaatz Received Received
  PB-449 Reversal of Direct Factor Xa Inhibitor-Associated Major Bleeding with Four-factor Prothrombin Complex Concentrate: A Systematic Review and Meta-analysis Siavash Piran Received Received
  PB-450 Resumption of Anticoagulant Therapy after Anticoagulant-Related Gastrointestinal Bleeding: A Systematic Review and Meta-analysis Derek Little Received Received
  PB-452 Recurrent Thrombosis in Patients with Antiphospholipid Antibodies Treated with Vitamin K Antagonists or Rivaroxaban Maria Abbattista Received Received
  PB-454 Variable Response in Individuals to Rivaroxaban and Apixaban over Time Suzanne Zwaveling Received Received
  PB-455 Effect of Anti-arrhythmic Medication Drug Interactions on Thrombotic and Bleeding Outcomes in Patients with Atrial Fibrillation Matthew Wanat Received Received
  PB-456 Lean Body Weight is the Best Scale for Venous Thromboprophylaxis Algorithm in Severely Obese Patients Undergoing Bariatric Surgery Corinne Frere Received Received
  PB-458 Post Analytical External Quality Assessment of Anticoagulant Dosing for Warfarin Therapy Dianne Kitchen Received Received
  PB-459 Creation of an Algorithm for Predicting Doses of Warfarin < 17.5mg Using CYP2C9 and VKORC1 Polymorphisms and Non-genetic Factors Maria Auxiliadora Parreiras Martins Received Received
  PB-460 Warfarin Use Increases Bleeding Risk in Hemodialysis Patients with Atrial Fibrillation: Evidence from Meta-analysis Using Real World Data Salman Hussain Received Received
  PB-461 Change of Rivaroxaban Anticoagulant Effect during the 24 Hours Olesya Matvienko Received Received
  PB-463 Flow Based Analysis of Heparin Inhibition of VWF Dependant Platelet Capture Amita Ranger Received Received
  PB-465 Real-world Experience of Direct Oral Anticoagulants Use in North Melbourne, Australia Hui Yin Lim Received Received
  PB-466 Relationship between Dabigratan Concentrations in Plasma and Results of Routine Coagulation Assays PT, APTT, TT and Fibrinogen Sandra Margetic Received Received
  PB-467 Measuring Anti-factor Xa Levels to Monitor Enoxaparin in Pregnant Women: A Prospective Comparative Study Fahad Aleidan Received Received
  PB-468 Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation in Clinical Practice: Outcomes from the First Observational and Prospective Study in Spanish Population Maria Cerdá Sabater Received Received
  PB-470 Multihospital System Implementation of the Anti-Xa for Titration for Monitoring Unfractionated Heparin (UH) Therapy Paul Lindholm Received Received
  PB-471 Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach Geoffrey Barnes Received Received
  PB-472 Impact of Rivaroxban on Platelet Reactivity and von Willebrand Factor Antigen and Activity in Patients with Venous Thrombosis Nina Schultz Received Received
  PB-473 Weekly Warfarin Maintenance Dose According to Variations in Four Genes Evaluated in Patients Assisted at a Brazilian Anticoagulation Clinic Maria Auxiliadora Parreiras Martins Received Received
  PB-477 Development, Implementation and Evaluation of Application for Monitoring Oral Anticoagulant Therapy Maria Auxiliadora Parreiras Martins Received Received
  PB-479 A Multicenter Experience with Idarucizumab "in Real World" as Reversal Anticoagulation of Dabigatrán Marta Villalba Montaner Received Received
  PB-481 Retrospective Observational Study of Patients Treated with Rivaroxaban in Saudi Arabia Muhammad Riazuddin Received Received
  PB-483 Description and Evaluation of the Comparison of Activated Partial Thromboplastin Time versus Anti-factor Xa Activity for Therapeutic Unfractionated Heparin Monitoring in a Tertiary Academic Medical Center using Three Different Adult Weight-based, Nurse Ma Laura Talamo Received Received
  PB-484 Idarucizumab for Reversing Anticoagulation in Patients Treated with Dabigatran: Experience in our Center Estefania Morente Constantin Received Received
  PB-485 Warfarin Dose Requirements in Patients with Heart Diseases Assisted at an Anticoagulation Clinic in the Southeast Brazil Maria Auxiliadora Parreiras Martins Received Received
  PB-486 Direct-acting Oral Anticoagulant Drug Level Monitoring in Clinical Patient Management Batia Roth Received Received
  PB-487 Establishment of a Centralized Monitoring System for Patients Receiving Anticoagulant Therapy in the Arkhangelsk Region Russia Nadezda Vorobyeva Received Received
  PB-488 Evaluation of Algorithms for Warfarin Dose Prediction Maria Auxiliadora Parreiras Martins Received Received
  PB-489 Development of an Educational Intervention Focused on Low-income Population Treated with Warfarin Maria Auxiliadora Parreiras Martins Received Received
  PB-491 Direct Oral Anticoagulant Use in Obese Patients: Preliminary Results of a Pilot Study Laura Talamo Received Received
  PB-492 Arterial Thrombosis Depends on Shear Rate More Than Shear Rate Gradient David Ku Received Received
  PB-493 Increased Platelet Count and Reticulated Platelets in Recently Symptomatic versus Asymptomatic Carotid Artery Stenosis and in Cerebral Microembolic Signal-negative Patient Subgroups: Results from the HEIST Study Stephen Murphy Received Received
  PB-495 Significance of Single Nucleotide Polymorphisms (SNPs) within Genes Encoding Platelet Glycoprotein Receptors in Patients with Infective Endocarditis (IE) Mariia Sorokina Received Received
  PB-496 Risk Factors for Brain Vessels´s ?hrombosis/Stenosis in Young Patients with Ischemic Stroke Tsvetomir Tsvetanov Received Received
  PB-497 In vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions Jonathan Douxfils Received Received
  PB-500 Resonance Raman Spectroscopy as a Tool to Study Blood Flow in Brain Vessels in vivo Evelina I. Nikelshparg Received Received
  PB-501 Assessing Three-dimensional Fibrin Polymerization Dynamics during Heparin Administration and Protamine Reversal in Cardiac Surgical Patients Diane Malu Tshikudi Received Received
  PB-503 Ir-CPI: An Original Inhibitor of Thrombosis and Thrombosis-associated with Cancer Edmond Godfroid Received Received
  PB-505 Effectiveness and Safety of Rivaroxaban versus Low Molecular-weight Heparin for Treatment of Cancer-associated Thromboembolism Craig I. Coleman Received Received
  PB-506 Optimizing Therapy for Venous Thromboembolism in Multiple Myeloma: A Systematic Review Samuel Abegunde Received Received
  PB-508 Comparative Efficacy and Safety of Anticoagulation for the Treatment of Cancer-associated Thrombosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials Craig I Coleman Received Received
  PB-509 A Monoclonal Antibody to Human Podoplanin Inhibits Human Platelet Aggregation Induced by Tumor Cells Yiming Zhao Received Received
  PB-510 D-dimer Levels for Prediction of Symptomatic Central Venous Catheter-related Thrombosis in Breast Cancer Patients Ilham Benzidia Received Received
  PB-511 Hypercoagulation Screening as Tool for Cancer Diagnosis: An Update on Tumor Incidence and Risk Factors in the HYPERCAN Study Sara Gamba Received Received
  PB-513 Cost-effectiveness of Edoxaban versus Dalteparin for Treatment of Cancer-associated Thrombosis Nathan Connell Received Received
  PB-514 Non-phosphorylated and Phosphorylated Signal Transduction Peptide (STP) of Tissue Factor (TF) in Urine Are Potential Biomarkers for Bladder and Colon Cancer Robert Greenfield Received Received
  PB-516 Leucocyte and Platelet Activation in Patients with BCR-ABL Negative Myeloproliferative Disorders Charlene Portelli Received Received
  PB-519 Evaluation of Risk Factors and Assessment Models for Predicting Venous Thromboembolism in Lung Cancer Patients Joanna Rupa-Matysek Received Received
  PB-520 Splanchnic Thrombosis Associted to Myeloproliferative Neoplasms: A Cohort of 233 Tunisian Patients Hadef Skouri Received Received
  PB-521 The Effect of Hydroxyurea on Blood Coagulation in Sickle Cell Disease Munira Borhany Received Received
  PB-522 The Effect of Inflammatory Cytokines IL-6, IL-10, IL-1b and TNFa on Thromboelastography Parameters in Pediatric Patients with Acute Lymphoblastic Leukemia Saskia Prasca Received Received
  PB-524 Clinical and Global Hemostatic Parameters in Patients with JAK2 V617F Mutation Myeloproliferative Neoplasms (MPNs) Aimwipa Sasakul Received Received
  PB-525 Generation of Neo-epitopes on Hypochlorous Acid-modified Human Antithrombin: An Immunological Study Parvez Ahmad Received Received
  PB-527 The Usefulness of Standard and Derived ROTEM Parameters for DIC Prediction in Septic Patients Ecaterina Scarlatescu Received Received
  PB-528 Recombinant A2 Domain of von Willebrand Factor Attenuates Microthrombi Formation, Organ Injuries and D-dimer Levels in a Porcine Model of Methicillin-resistant Staphylococcus Aureus (MRSA) Sepsis-induced Disseminated Intravascular Coagulation (DIC) Miguel Cruz Received Received
  PB-529 The Expression of Tissue Factor between Monocyte Subsets: A Role in Sepsis-associated Coagulopathy? Kathryn Mary Musgrave Received Received
  PB-530 Added Value of the DIC Score and of D-dimer to Predict Outcome after Successfully Resuscitated Out-of-Hospital Cardiac Arrest Nina Buchtele Received Received
  PB-532 Evaluation of the Effectiveness of AT III Concentrate in Acute DIC-syndrome Nadezda Vorobyeva Received Received
  PB-533 von Willebrand Factor Interactions with Platelets and Leukocytes is Critical for Obesity-mediated Venous Thrombosis Alison Michels Received Received
  PB-534 Iron Deficiency Increases Platelet Procoagulant Capacity in a Ferric Chloride Model of Arterial Thrombosis Kristine Jimenez Received Received
  PB-541 A Highly Efficient and Adhensive Antibacterial Dextran Derivative for Rapid Hemostasis with Wound Healing Chunyu Liu Received Received
  PB-543 Normal to High Anti-Xa Levels in High Body Weight Patients Using Apixaban and Rivaroxaban Zahra Mahir Received Received
  PB-544 Global Coagulation Assay Changes in Patients with Chronic Renal Impairment Hui Yin Lim Received Received
  PB-545 Assessment of the Agreement between the International Normalised Ratio (INR) Values Obtained by Applying Two Different Reagent/Instrument Combinations Alicia Noemi Blanco Received Received
  PB-547 The Coagulation System State in Patients with Philadelphia-negative Myeloproliferative Neoplasms Olesya Matvienko Received Received
  PB-548 Thromboelastographic Changes in Patients with BCR-ABL Negative Myeloproliferative Disorders Marie Claire Cini Received Received
  PB-549 The Impact of Age, Ethnicity and Gender on Global Coagulation Assays Hui Yin Lim Received Received
  PB-551 Identification of Protein C System-associated Thrombophilia using an Endothelial Cell-based Thrombin Generation Assay Ali Amirkhosravi Received Received
  PB-554 A Rapid Fully-automated Chemiluminescent Immunoassay for the Early Quantification of ADAMTS13 Activity in TTP Diagnosis Carla Valsecchi Received Received
  PB-555 Urgent Laboratory Investigation of HIT Syndrome with an Automated Immunoassay in Cardiovascular Patients Theodora Kostelidou Received Received
  PB-556 Platelet Hyporeactivity Combined with Enhanced Coagulation in Healthy Term and Preterm Newborns During First Days of Life Ekaterina Koltsova Received Received
  PB-557 Von Willebrand Factor Antigen Levels Predict Major Adverse Cardiovascular Events in Patients with Asymptomatic Carotid Stenosis Katarina D. Kovacevic Received Received
  PB-558 Thrombin Generation in Real-world Patients Treated with Two Different Doses of Apixaban María De Lourdes Herrera Received Received
  PB-560 Active von Willebrand Factor Levels in Kidney Disease Are Associated with Disease Severity and Type of Dialysis Lisa N. van der Vorm Received Received
  PB-561 Role of Thromboelastography to Assess Thrombin Generation in Acute Coronary Syndrome (ACS) Qiuya Lu Received Received
  PB-563 Laboratory Assessment of Dabigatran Levels and Anti-Xa Anticoagulant Levels Ivanka Paskaleva Received Received
  PB-566 Natural Anticoagulant Deficiencies in Thais: A Population-based Study Ponlapat Rojnuckarin Received Received
  PB-567 Changes in Tissue Factor Concentration and APTT in Haemolysed and Non-haemolysed Paired Citrate Samples Kieron Hickey Received Received
  PB-569 DOAC Filter Effect on Thrombin Generation: Pre-analytical Considerations and Analytical Perspectives Damien Gheldof Received Received
  PB-570 Heparin-induced Thrombocytopenia: An International Assessment of the Quality of Laboratory Testing Zachary Liederman Received Received
  PB-571 A Comparison of Two Point-of-Care Testing Platforms (Coaguchek® Pro II and Coaguchek® INRange) to Standard Laboratory Measurement of the International Normalised Ratio Shu Hui Yeang Received Received
  PB-572 Measurement of Coagulation Factors during Rivaroxaban and Apixaban Treatment: Results from Two Crossover Trials Luuk J.J. Scheres Received Received
  PB-573 Stability of Thrombin Generation and Thrombin Dynamics in Healthy Individuals over a One-year Period Joke Konings Received Received
  PB-574 The Association of Hereditary Thrombophilia with Clinically Relevant Hypercogulation State and Free Flap Thrombosis in Microvascular Surgery Karina Drizlionoka Received Received
  PB-575 Use of a Liquid Recombinant Thromboplastin (DG-PT RecombiLIQ, Diagnostic Grifols) for Monitoring Vitamin K Antagonist Therapy Anita Woolley Received Received
  PB-576 Heparin Anti-Xa Assay versus Activated Partial Thromboplastin Time to Monitor Unfractionated Heparin during Extracorporeal Membrane Oxygenation Deepa Jayakody Arachchillage Received Received
  PB-577 An Automated Modified Anti-Xa Assay for the Potency Assessment of Bemiparin in Pharmaceutical Formulations Alejandra Scazziota Received Received
  PB-580 Limits to Sensitivity of 4T Score for Heparin Induced Thrombocytopenia Deepa Jayakody Arachchillage Received Received
  PB-581 External Quality Assessment of Point of Care Testing in Haemostasis Shelene Munroe-Peart Received Received
  PB-582 Clot Waveform Analysis for Measuring and Quantifying Fibrin Clot Formation Jonathan Evrard Received Received
  PB-583 The Calibrated Automated Thrombography in Patients with Factor XII Deficiency Natalya Silina Received Received
  PB-584 Thrombin Generation Analysis with a New Automated System (ST-Genesia): Inter-series Performances during DRIVING Study and Comparison with CAT System Virginie Siguret Received Received
  PB-586 D-dimer Measurement: Lipid Interference Removal through High-speed Centrifugation Audrey Carlo Received Received
  PB-588 Development of a HPLC-UV Method for the Measurement of Dabigatran from Plasma and its Application as Reference Method for the Evaluation of a Novel Chromogenic Dabigatran Assay Anita Kuruczné Kern Received Received
  PB-589 Fibrinolysis System and Combined oral Contraceptives Nadezda Vorobyeva Received Received
  PB-591 Reference Change Value for INR: A Simple Tool for Management of Patients on Oral Anticoagulation Alejandra Scazziota Received Received
  PB-593 Reproducibility of Rotem® Device Erica Scalambrino Received Received
  PB-594 Taipan Snake Venom Time Detects the Lupus Anticoagulants in Anticoagulated, Triple-positive Antiphospholipid Syndrome Patients Gary William Moore Received Received
  PB-596 Improving Lupus Anticoagulant Testing with 2 New APTT and dRVVT Reagents Corinne Frere Received Received
  PB-598 Validation of an Automated Algorithm for Interpretation of Lupus Anticoagulant Testing on Stago STA-R Max Lisa Florin Received Received
  PB-599 Thrombin Generation Test in Detection of Prothrombotic Phenotype in Asymptomatic Carriers of the FV G1691A or/and FII G20210A Mutations Olesia Matvienko Received Received
  PB-600 Management of Direct Oral Anticoagulants for Low-bleeding Risk Surgery: The Example of Cataract Surgery Anne Godier Received Received
  PB-601 Using Drug Levels to Guide Peri-operative Management of Direct Oral Anticoagulants Prior to Emergency Orthopaedic Surgery; Experience from a Large Teaching Hospital within the UK Emily Millen Received Received
  PB-603 Antithrombin Levels Less than 60% Lead to Reduced Anti-Xa Levels Claire Pillion Received Received
  PB-605 Inpatient to Outpatient Transition of Care for Pediatric Patients with Venous Thromboembolism James Munn Received Received
  PB-606 Cerebral Sinovenous Thrombosis (CSVT) in Children: 25 Years Single-center Prospective Pediatric Cohort in Argentina Gabriela Sciuccati Received Received
  PB-607 Significance of GPIba -5T>C, GPIba VNTR, GPVI T13254C Polymorphisms and HPA-2 in the Etiology of Pediatric Arterial Ischemic Stroke Desiree Coen Herak Received Received
  PB-610 D Dimer Levels and Thrombosis in Children with Systemic Lupus Erythematosus Jasmina Ahluwalia Received Received
  PB-611 Anti-factor H Autoantibody-associated Hemolytic Uremic Syndrome in an Argentinean Pediatric Cohort Célia Dos Santos Received Received
  PB-613 Prosthetic Valve Thrombosis in Children Patricia Kewada Received Received
  PB-614 Towards a Consensus for Standardized Assessment of Pediatric Patients with Vascular Malformations (VM) at Risk for Coagulopathy Leonardo Brandao Received Received
  PB-616 Dosing, Safety and Efficacy of Therapeutic and Prophylactic Low Molecular Weight Heparin in the Pediatric Population: A Systematic Review Irene Lisette Maria Klaassen Received Received
  PB-617 Exploring Adolescent´s Perceptions and Emotional Reaction to Thrombosis and Anti-coagulant Therapy: A Qualitative Study Tina Biss Received Received
  PB-621 How do Adolescents Experience Anticoagulant Adherence? A Qualitative Exploration of the Barriers and Facilitators Kay Anne Rooney Received Received
  PB-624 Spontaneous Thrombosis in a Patient With Factor XI Deficiency Homozygous for the p.Cys398Tyr Mutation Utku Aygüne Received Received
  PB-626 The Joint Effect between Different Types of Combined Oral Contraceptives and Genetic Risk Factors on Venous Thrombosis Risk: Results from the MEGA Case-control Study Deeksha Khialani Received Received
  PB-627 Risk of Recurrent Venous Thromboembolism in Pregnancy and Postpartum Period: Results from the MEGA Follow-up Study Luuk J.J. Scheres Received Received
  PB-628 Misuse of Low Molecular Heparin in Pregnancy Julija Samonikov Tosevska Received Received
  PB-629 Written Alert System Improves Thromboprophylaxis Compliance in Caesarean Women Cecilia Guillermo Received Received
  PB-631 Management of Venous Thromboembolism (VTE) during Pregnancy and Post-partum: Findings from the Indian Subset of an International, Observational Study (SAVE) Ravi Mohan Tiwari Received Received
  PB-632 Thrombin Generation and Adverse Pregnancy Outcomes Irina Gribkova Received Received
  PB-634 Reduced Protein C Global Assay Level in Infertile Women with IVF Failure: A Pilot Study Hanan azzam Received Received
  PB-635 Hereditary Thrombophilia Assessment in Pregnancy Tatjana Makarovska Bojadzieva Received Received
  PB-636 Localization and Massiveness of Thrombosis in Women with Pregnancy Related Thrombosis Compared to Women with Unprovoked Venous Thromboembolism Predrag Miljic Received Received
  PB-637 Prospective Study of Changes in Haemostasis in High-risk Pregnancy Lucia Stanciakova Received Received
  PB-638 Risk Assessment of Venous Thromboembolism (VTE) during Pregnancy and Post-partum: Findings from the Indian Subset of an International, Observational Study (SAVE) Ravi Tiwari Received Received
  PB-639 Genetic Risk Factors of Endothelial Dysfunction in Pregnant Women Natalya Silina Received Received
  PB-640 Characterization and Outcomes of aTTP Patients with Initial or Recurrent Disease: Experience from the Phase III HERCULES Trial of Caplacizumab Hilde De Winter Received Received
  PB-641 Efficacy and Safety of Open-label Caplacizumab in Patients with Exacerbations of Acquired Thrombotic Thrombocytopenic Purpura during the Phase III HERCULES Study Filip Callewaert Received Received
  PB-642 Treatment of Acquired TTP with the Anti-vWF Nanobody, Caplacizumab, Results in a Significant Reduction in Healthcare Resource Utilization - Data from the Phase III HERCULES Trial Filip Callewaert Received Received
  PB-644 Initial Clinical Presentation of Thrombotic Thrombocytopenic Purpura with Focal Stroke: A Series of Patients from the French National Reference Center Registry for Thrombotic Microangiopathies Maxime Delrue Received Received
  PB-645 Provision of an External Quality Assessment for ADAMTS13 Ian Jennings Received Received
  PB-647 Pre-test Likelihood of ADAMTS13 Severe Deficiency in the Context of Thrombotic Microangiopathies: Validation of the PLASMIC Score in a Southern Italy Hospital Elvira Grandone Received Received
  PB-648 "How we Treat": Recurrent TTP Patients Undergoing Elective Surgery Sara Arcudi Received Received
  PB-652 Identification of Novel ADAMTS13 Gene Mutation in a Patient with Congenital Thrombotic Thrombocytopenic Purpura Anila Rashid Received Received
  PB-654 Evaluation of Hospital Readmissions among Patients Hospitalized for Acute Medical Illness and at Risk for Venous Thromboembolism in the US Richey Neuman Received Received
  PB-655 Comparison of the Risk of Recurrence in Patients with Venous Thromboembolism (VTE) Provoked by Major and Minor Surgery and Trauma Tiago Gregorio Received Received
  PB-656 Comparative Thrombosis Risk of Vascular Access Devices among Critically Ill Medical Patients Scott M Stevens Received Received
  PB-657 Cost-effectiveness of Betrixaban Compared with Enoxaparin for Primary Venous Thromboembolism Prophylaxis in Hospitalised Acute Medically Ill Patients in the United States Andrea Hafeman Received Received
  PB-658 Venous Thromboembolism Clinical Risk Assessment Model for Patients with a Lower Limb Trauma Requiring Immobilization: The TIP Score Pierre-Marie Roy Received Received
  PB-660 A Single Center Analysis of Pre-, Intra- and Post-operative Thrombotic Events in a Cohort of 470 Orthotopic Whole Liver Transplantations Nicoletta Riva Received Received
  PB-661 miRNA Expression Profile in Venous Thrombosis Disease: Results from the Genetic Analysis of Idiopathic Thrombophilia Project Alba Rodriguez-Rius Received Received
  PB-662 Clinical Characteristics and Outcome of Patients with Subsegmental Pulmonary Embolism Farès Moustafa Received Received
  PB-663 Assessment of General Awareness of Thrombosis and How Best to Communicate this Information Ann Marie O´Neill Received Received
  PB-664 Postoperative Venous Thromboembolism Prophylaxis in Perioperative Trials of Tranexamic Acid: A Systematic Review and Meta-analysis Joshua Taylor Received Received
  PB-665 Testosterone Therapy and Venous Thromboembolism: A Systematic Review and Meta-analysis Damon E Houghton Received Received
  PB-666 Homozygotes in FXI rs 2289252 and ABO rs 8176719 Have a Low Risk of VTE Recurrence Jan Kvasnicka Received Received
  PB-667 Risk of Pulmonary Embolism after Surgical Resection of Meningioma Andrea Artoni Received Received
  PB-668 Lower-leg Injury Leads to a Procoagulant State Carolina E. Touw Received Received
  PB-670 The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism Éva Katona Received Received
  PB-671 Risk Stratification for Prevention of Venous Thromboembolism in Hospitalized Medical Patients: Can Thromboprophylaxis in Hospitalized Medical Patients Be Safely Restricted to Reduce Costs? Alison Mary Bond Received Received
  PB-672 Predictors of Venous Thromboembolism in Patients Undergoing Neurosurgery for Glioma Marco Capecchi Received Received
  PB-673 IVSS Safety Zone Protocol vs Padua Score in the Prevention of Thromboembolic Disease in Medical Patients: A Comparative Prospective Study Juan Serrano Received Received
  PB-680 25mmHg vs. 35 mmHg Graduated Elastic Compression Stockings to Treat Acute Symptoms of Deep-Vein Thrombosis: The CELEST Double-blind Trial Jean-Philippe galanaud Received Received
  PB-681 Individualized Prediction Model for Risk of First DVT Using Clinical Assessment and D-dimer Sameer Parpia Received Received
  PB-682 Long-term Risk of Post-thrombotic Syndrome after Symptomatic Distal Deep-vein Thrombosis: The CACTUS-PTS Study Jean-Philippe Galanaud Received Received
  PB-683 Age-adjusted versus Clinical Probability-adjusted D-dimer to Exclude Pulmonary Embolism Scott M Stevens Received Received
  PB-684 Vena Caval Filters in Patients Presenting with Major Bleeding during Anticoagulation for Venous Thromboembolism Farès Moustafa Received Received
  PB-685 Whole Leg Ultrasound for the Diagnosis of Deep Vein Thrombosis Recurrence Michelangelo Sartori Received Received
  PB-688 Clinical Predictors of Right Ventricular Dysfunction in Acute Pulmonary Thromboembolism Jose Bonorino Received Received
  PB-689 Individualized Thromboprophylaxis in Patients with Lower-leg Cast Immobilization - A Validation and Subgroup Analysis in the POT-CAST Trial Banne Nemeth Received Received
  PB-690 Prevalence of Pulmonary Embolism in Patients Presenting to the Emergency Department with Syncope in an Integrated Healthcare System Scott S. Stevens Received Received
  PB-693 Assessment of D-dimer Value at First Venous Thromboembolism and Risk of Recurrence Rosa Vidal Received Received
  PB-695 A Systematic Review to Determine Patient Preferences to Receive Thromboprophylaxis to Prevent Deep Vein Thrombosis and Pulmonary Embolism Natasha Dembrey Received Received
  PB-696 Efficacy and Safety of Rivaroxaban and Apixaban in Relation to Low Molecular Heparin and Vitamin K Antagonists in Acute Venous Thromboembolism - A Single Center Prospective Study Waldemar Wysokinski Received Received
  PB-697 Circulating Endothelial Cells as a New and Early Candidate Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism Nicolas Gendron Received Received
  PB-698 Thrombophlebitis Post Varicose Vein Surgery: To Treat or Not to Treat? Hui Yin Lim Received Received
  PB-699 Comparison of Risk Assessment Methods to Prevent Venous Thromboembolism (VTE) in Surgical Patients with Short Length of Hospital Stay Maria Chiara Chindamo Received Received
  PB-701 Effectiveness and Safety of Outpatient Rivaroxaban versus Warfarin in Patients with Provoked Acute Venous Thromboembolism Craig I Coleman Received Received
  PB-702 Rivaroxaban and Apixaban for Treatment of Acute Isolated Calf Deep Vein Thrombosis - A Single Center Prospective Study Robert McBane Received Received
  PB-704 The Relationship between Neutrophil Lymphocyte Ratio and Deep Vein Thrombosis in Unilateral Limb Edema in Suspected Deep Vein Thrombosis Patients Ikhwan Rinaldi Received Received
  PB-705 Application of an Explanatory Model for Emergency Physician Pulmonary Embolism Testing in a National Cohort Sahar Zarabi Received Received
  PB-706 Deep Dive into DVTs: A 3 Year Retrospective Review of Patients with Deep Vein Thrombosis (DVT) on an Ambulatory Integrated Care Pathway (ICP) V Graham Received Received
  PB-707 The Association of Characteristics of Central Venous Catheters with Venous Thrombotic Events in Pediatric Patients Undergoing Fontan Surgery Ketan Kulkarni Received Received
  PB-708 Implementation of an Acute DVT Ambulatory Care Pathway in a Large Urban Centre: Current Challenges and Future Opportunities Sarah Kelliher Received Received
  PB-709 Treatment Satisfaction with Rivaroxaban for the Management of Venous Thromboembolism (VTE) - Early Results from the ´Follow-up in Rivaroxaban Patients in Setting of Thromboembolism´ (FIRST) Registry Victoria Speed Received Received
  PB-711 Evaluation of an Educational Video for Patients Taking Warfarin Maria Auxiliadora Parreiras Martins Received Received
  PB-712 Subsegmental Pulmonary Embolism: An Innocent Bystander? Myrthe Carlijn Gerritsen Received Received
  PB-714 Outpatient Management of Deep Vein Thrombosis using Direct Oral Anticoagulants is Safe and Cost-effective Hui Yin Lim Received Received
  PB-715 Knowledge Derived from a Hospitalar Thromboprophylaxis Program Maria Chiara Chindamo Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30, Fri 8:30-15:00
16:56
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTA..

64th Annual ISTH SSC Meeting

 

18-21 July 2018 Dublin
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 18/07/2018 TO 18/07/2018
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.SSC2018.2018 
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 01/07/2018
Upload Poster
Upload Oral Presentation of Video
Check your Poster
Upload
Poster
Upload Oral
Presentation or Video
Check
your Poster




PosterSessionOnline
Logo Draft
 
Logo Cert